Aimovig, a new kind of migraine drug, is injected once a month. The medicine reduced the number of migraines in clinical studies reviewed by the Food and Drug Administration. (Source: Amgen/AP)
Aimovig, a new kind of migraine drug, is injected once a month. The medicine reduced the number of migraines in clinical studies reviewed by the Food and Drug Administration. (Source: Amgen/AP)